Pertuzumab

Authors

Publication Details

Journal
Canadian Journal of Health Technologies
Published
2025-10-03
DOI
https://doi.org/10.51731/cjht.2025.1248
Primary Topic
Eosinophilic Disorders and Syndromes
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Pertuzumab

CDA-AMC
Canadian Journal of Health Technologies
Eosinophilic Disorders and Syndromes
article

Pertuzumab

CDA-AMC
article en

Abstract

No abstract available for this paper.
Canadian Journal of Health TechnologiesVol. 5(10)
Openalex Percentile: Top 59%
Eosinophilic Disorders and Syndromes
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Pertuzumab — CDA-AMC · Canadian Journal of Health Technologies (2025) | TGRS Research Map | TGRS